2019 annual financial data
Sarepta Therapeutics 2019 Operating margin
Direct answer
Operating margin was -185.27%.
Operating income was -705,563,000 USD and net income was -715,075,000 USD.
Operating cash flow was -456,463,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 380,833,000 USD
- Operating income
- -705,563,000 USD
- Net income
- -715,075,000 USD
- Operating cash flow
- -456,463,000 USD